Pharmacokinetics of Oral Acyclovir in Neonates and in Infants: a Population Analysis

Acyclovir is approved for the treatment of herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections in children by the intravenous and oral routes. However, its use by the oral route in children younger than 2 years of age is limited due to a lack of pharmacokinetic data. The objective...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Tod, M., Lokiec, F., Bidault, R., De Bony, F., Petitjean, O., Aujard, Y.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2001
Aiheet:	Pharmacology
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90253/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11120958/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.1.150-157.2001
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!